7E36
A [6+4]-cycloaddition adduct is the biosynthetic intermediate in streptoseomycin biosynthesis
Summary for 7E36
| Entry DOI | 10.2210/pdb7e36/pdb |
| Descriptor | Alkanesulfonate monooxygenase SsuD/methylene tetrahydromethanopterin reductase-like flavin-dependent oxidoreductase (Luciferase family), FMN-dependent oxidoreductase (Nitrilotriacetate monooxygenase family), SULFATE ION, ... (8 entities in total) |
| Functional Keywords | nargenicin, biosynthetic protein, oxidase, oxidoreductase |
| Biological source | Nocardia tenerifensis More |
| Total number of polymer chains | 2 |
| Total formula weight | 81575.15 |
| Authors | |
| Primary citation | Wang, K.B.,Wang, W.,Zhang, B.,Wang, X.,Chen, Y.,Zhu, H.J.,Liang, Y.,Tan, R.X.,Ge, H.M. A [6+4]-cycloaddition adduct is the biosynthetic intermediate in streptoseomycin biosynthesis. Nat Commun, 12:2092-2092, 2021 Cited by PubMed Abstract: Streptoseomycin (STM, 1) is a bacterial macrolactone that has a unique 5/14/10/6/6-pentacyclic ring with an ether bridge. We have previously identified the biosynthetic gene cluster for 1 and characterized StmD as [6 + 4]- and [4 + 2]-bispericyclase that catalyze a reaction leading to both 6/10/6- and 10/6/6-tricyclic adducts (6 and 7). The remaining steps, especially how to install and stabilize the required 10/6/6-tricyclic core for downstream modifications, remain unknown. In this work, we have identified three oxidoreductases that fix the required 10/6/6-tryciclic core. A pair of flavin-dependent oxidoreductases, StmO1 and StmO2, catalyze the direct hydroxylation at [6 + 4]-adduct (6). Subsequently, a spontaneous [3,3]-Cope rearrangement and an enol-ketone tautomerization result in the formation of 10/6/6-tricyclic intermediate 12b, which can be further converted to a stable 10/6/6-tricyclic alcohol 11 through a ketoreduction by StmK. Crystal structure of the heterodimeric complex NtfO1-NtfO2, homologues of StmO1-StmO2 with equivalent function, reveals protein-protein interactions. Our results demonstrate that the [6 + 4]-adduct instead of [4 + 2]-adduct is the bona fide biosynthetic intermediate. PubMed: 33828077DOI: 10.1038/s41467-021-22395-7 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report






